This study identified increased age, reduced absolute counts of CD4+CD28− T cells, and elevated absolute counts of CD4+CD38− T cells as independent risk factors for CRF in pan-cancer patients, as determined by multivariate logistic regression analysis. This evidence concerns the gene CD38 and cancer.